Far too often strong scientific research that could benefit patients is left on the shelves of academia because it can’t get the funding needed to move it forward. At BridgeBio, we are focused on forging meaningful partnerships with academic institutions to support and accelerate the work of researchers who are on the front lines of understanding how genetic diseases may be treated.
We feel privileged to be partnered with top academic and research institutions that share our commitment to discover, create, test and deliver life-changing medicines for patients with genetic diseases and cancers with clear genetic drivers.
We value scientific innovation and believe in the importance of collaborating with healthcare, pharmaceutical and biotechnology companies on research, clinical development and commercialization with the aim of reaching as many patients in need as possible.
Below please find a few of our global industry partners.
We are privileged to have developed relationships with many leading institutions and companies across our industry. Our door is always open to the right partner who can help us advance our mission of developing life-changing medicines for patients that target debilitating diseases at their source.